|
|
|
|
|
|
|
|
"According to the manufacturer, the lamellae result from the interaction of the formulation with glass vials during the shelf life of the product. However, the company states that it has found that the lamellae have a low potential to affect patients who may have received the recalled product. "To date, there have been no complaints or adverse events reported which can be directly attributed to the presence of glass lamellae," the company notes."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.